tiprankstipranks
Trending News
More News >
TELA Bio (TELA)
NASDAQ:TELA
US Market

TELA Bio (TELA) Financial Statements

Compare
167 Followers

TELA Bio Financial Overview

TELA Bio's market cap is currently $44.98M. The company's EPS TTM is $-0.19; its P/E ratio is -1.12; TELA Bio is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 69.30M$ 58.45M$ 41.42M$ 29.46M$ 18.21M
Gross Profit$ 46.49M$ 40.11M$ 27.04M$ 18.81M$ 11.23M
Operating Income$ -34.12M$ -44.08M$ -39.01M$ -29.45M$ -25.27M
EBITDA$ -31.68M$ -40.63M$ -39.06M$ -29.14M$ -24.70M
Net Income$ -37.84M$ -46.66M$ -44.30M$ -33.28M$ -28.79M
Balance Sheet
Cash & Short-Term Investments$ 52.67M$ 46.73M$ 42.02M$ 43.93M$ 74.39M
Total Assets$ 87.33M$ 78.05M$ 67.86M$ 62.54M$ 86.46M
Total Debt$ 43.06M$ 42.77M$ 41.46M$ 31.49M$ 30.83M
Net Debt$ -9.61M$ -3.96M$ -563.00K$ -12.44M$ -43.57M
Total Liabilities$ 58.87M$ 59.17M$ 53.55M$ 42.45M$ 37.43M
Stockholders' Equity$ 28.46M$ 18.88M$ 14.30M$ 20.10M$ 49.03M
Cash Flow
Free Cash Flow$ -42.58M$ -41.47M$ -42.62M$ -31.06M$ -24.62M
Operating Cash Flow$ -41.59M$ -40.86M$ -40.75M$ -30.43M$ -24.46M
Investing Cash Flow$ 4.45M$ -599.00K$ -1.87M$ -627.00K$ 9.12M
Financing Cash Flow$ 43.06M$ 46.27M$ 40.85M$ 585.00K$ 44.41M
Currency in USD

TELA Bio Earnings and Revenue History

TELA Bio Debt to Assets

TELA Bio Cash Flow

TELA Bio Forecast EPS vs Actual EPS